Researchers from AstraZeneca and Veradigm have published two new studies in the International Journal of Chronic Obstructive Pulmonary Disease leveraging de-identified patient data sourced from a nationwide, electronic health record platform and linked to claims data.
To learn more about the specific findings of these studies, download these articles from AstraZeneca and Veradigm now.